Skip to content
Saturday, November 14, 2026
Discover the finest luxury experiences, exclusive events, a…

Giving Pluripotent Cells in Utero to Babies with Neural Tube Defect Improves Quality of Life, Research Shows

A pioneering medical trial has found that delivering regenerative cells to developing infants affected by spina bifida as part of a surgical repair may represent a "important advancement" in managing prenatal disorders.

Study Parameters and Security

The US-based trial focused on six unborn babies with the 'open' form of spina bifida. Surgeons applied placenta-derived mesenchymal stem cells on the exposed area of the baby's spinal cord as part of the surgical correction.

Critically, the cell therapy demonstrated a favorable safety profile. The study team reported that the treatment did not lead to cancerous growths, disrupt the healing process, or impede the resolution of co-occurring hindbrain herniation.

Encouraging Results

Magnetic resonance imaging performed on the newborns showed a full resolution of Chiari malformation in all six infants. This favorable anatomical change is closely linked to better mobility and function.

"In the event it allows more children to achieve ambulation who wouldn't have, then it would become the conventional approach," commented the principal investigator. "The outcomes appear extremely promising and pave the way for a variety of prospective innovative interventions."

Broader Impact and Encouragement

Experts not involved in the trial proposed that additional validation of these apparent benefits could signal a "new era" in fetal surgery. The prospect of enhancing neurological damage occurring during fetal development is regarded as a paradigm-shifting aim.

Notably important would be advancements for bladder and bowel function, which are common challenges for individuals living with this condition.

Looking Ahead

Despite this being a first-in-human effort focused on a handful of cases, its safety demonstration and positive signals offer a robust platform for broader investigative efforts. The integration of stem cell therapy with proven prenatal surgical methods holds considerable promise for improving the prognosis for future generations with myelomeningocele.

Written by

Daniel Hooper

Lifestyle journalist and luxury travel expert with a passion for uncovering London's hidden gems.

London VIP Corner

Type to search articles.